Echocardiographic Changes After 3-hydroxy Butyrate+Whey Intake
Echocardiographic Changes After Oral Intake of 3-hydroxy Butyrate+Whey in a Human Endotoxemia Model
Sponsor: Aarhus University Hospital Skejby
A NA clinical study on Cardiac Output and Catabolic State, this trial is completed. The trial is conducted by Aarhus University Hospital Skejby and has accumulated 7 data snapshots since 2019. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jul 2020 — Jan 2021 [monthly]
Completed NA
Status: Recruiting → Completed
-
Apr 2020 — Jul 2020 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Sep 2019 — Apr 2020 [monthly]
Recruiting NA
-
Aug 2019 — Sep 2019 [monthly]
Recruiting NA
First recorded
Jun 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Aarhus University Hospital Skejby
- Arla Food Ingredients, Arla Viby.
- University of Aarhus
For direct contact, visit the study record on ClinicalTrials.gov .